Are new technologies for detection and treatment of non-muscle-invasive bladder cancer (NMIBC) so important? A plea for adoption by teaching programs to improve results after standard white light transurethral resection of NMIBC

European Urology

Volumn 61, Issue 5, 2012, Pages 914-916

  Brausi, Maurizio ^a  

^a B Ramazzini Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; MITOMYCIN C;

BLADDER CANCER; CANCER DIAGNOSIS; CANCER SURGERY; COST EFFECTIVENESS ANALYSIS; CYSTOSCOPY; EDITORIAL; HEALTH CARE COST; HUMAN; NARROW BAND IMAGING CYSTOSCOPY; NON MUSCLE INVASIVE BLADDER CANCER; PRIORITY JOURNAL; RECURRENT CANCER; TRANSURETHRAL RESECTION;

CARCINOMA; CYSTECTOMY; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; URINARY BLADDER NEOPLASMS;

EID: 84859424749     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.02.023     Document Type: Editorial

References (10)

1. K. Gono, T. Obi, and M. Yamanuchi Appearance of enhanced tissue features in narrow-band endoscopic imaging J Biomed Opt 9 2004 568 577
2. A. Naselli, C. Introini, and L. Timossi A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence Eur Urol 61 2012 908 913
3. K.-H. Kurth, and R. Sylvester Prognostic factors in non-muscle-invasive bladder tumors: I. Clinical prognostic factors: a review of the experience of the EORTC Genito-Urinary Group II. Biologic prognostic markers Eur Urol Suppl 6 2007 789 799 (Pubitemid 46978426)
4. M. Brausi, L. Collette, K. Kurth EORTC Genito-Urinary Tract Cancer Collaborative Group Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies Eur Urol 41 2002 523 531
5. M. Brausi, R. Sylvester, and A. van der Meijden Does the surgeon have an impact in the outcome of patients with Ta-T1 TCC of the bladder? Results of an EORTC quality control study on TURBT Eur Urol 39 Suppl 5 2001 119
6. M. Brausi, M. Gavioli, and G.C. Peracchia Dedicated teaching programs can improve the quality of TUR of non-muscle-invasive bladder tumours (NMIBT): experience of a single institution Eur Urol Suppl 7 2008 180
7. M.S. Soloway, D.S. Bruch, and S.S. Kim Expectant management of small, recurrent, non invasive papillary bladder tumours J Urol 170 2003 438 441 (Pubitemid 36870219)
8. S. Holmang, P. Andius, and H. Hedelin Stage progression in Ta papillary urothelial tumours: relationship to grade, immunohistochemical expression of tumour markers, mitotic frequency and DNA ploidy J Urol 165 2001 1124 1128 (Pubitemid 32210217)
9. M. Brausi Approaches to the management of non-muscle invasive bladder cancer: a review of current guidelines and best practice recommendations from the International Bladder Cancer Group Eur Urol Suppl 7 2008 615 617
10. A.P. Van der Meijden, R.R. Hall, and K.H. Kurth Phase II trials in Ta-T1 bladder cancer: the marker tumor concept Br J Urol 77 1996 634 638